News
- Author:
- Will Pass
Publish date: December 12, 2022
"This work highlights the need for standardized and continual depression and anxiety screening in ob.gyn. and primary care settings."
News
- Author:
- Will Pass
Publish date: December 6, 2022
A new analysis adds to a growing body of evidence supporting a range of positive benefits from dapagliflozin.
News
- Author:
- Will Pass
Publish date: December 5, 2022
The parents of the child who had a severe case of RSV reflected on the their son’s bout with the illness.
News
- Author:
- Will Pass
Publish date: November 14, 2022
Preschool boys and girls exposed to violent content in cartoons or other shows are more likely at age 12 to show greater emotional distress, less c...
News
- Author:
- Will Pass
Publish date: November 3, 2022
With further development, the model could be used to identify at-risk children via electronic medical records, enabling earlier monitoring and inte...
News
- Author:
- Will Pass
Publish date: November 1, 2022
Past studies generally included only male subjects, which has prevented detection of possible sex-linked differences in IL-22-related pathophysiolo...
News
- Author:
- Will Pass
Publish date: November 1, 2022
Researchers say inequities likely stem from structural racism and income inequality.
News
- Author:
- Will Pass
Publish date: October 28, 2022
A cohort study finds more than half of the most viewed social media videos on colonoscopy contain inaccurate or contradictory information.
News
- Author:
- Will Pass
Publish date: October 26, 2022
All four drugs – cocaine, methamphetamine, opioids, and cannabis – whether stimulants or depressants – cause “quite dramatic and often rapid effect...
News
- Author:
- Will Pass
Publish date: October 21, 2022
The researchers saw lower mortality and clinical severity among statin users.
News
- Author:
- Will Pass
Publish date: October 20, 2022
Compared with adalimumab, JAK inhibitors presented no higher risk of major adverse cardiovascular events or venous thromboembolism in patients with...
News
- Author:
- Will Pass
Publish date: October 18, 2022
Compared with rivaroxaban, patients who received apixaban had a 43% reduced risk of stroke or embolism.
News
- Author:
- Will Pass
Publish date: October 10, 2022
New mouse models that demonstrate how higher body temperature reduces levels of mevalonate kinase can serve as “preclinical platforms” to test the ...
News
- Author:
- Will Pass
Publish date: October 6, 2022
The results of this trial suggest that microbiota restoration might be necessary to obtain sustained resolution following C. difficile inf...
News
- Author:
- Will Pass
Publish date: October 6, 2022
The results of this trial suggest that microbiota restoration might be necessary to obtain sustained resolution following C. difficile inf...
